Pathogenesis, Targeted Therapeutics, and New Vaccines for Childhood Disease
儿童疾病的发病机制、靶向治疗和新疫苗
基本信息
- 批准号:10613453
- 负责人:
- 金额:$ 44万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-02-08 至 2026-03-31
- 项目状态:未结题
- 来源:
- 关键词:Academic Medical CentersAptitudeAreaCancer BiologyChildhoodCollaborationsCommunicable DiseasesCore FacilityCoupledDiabetes MellitusDiseaseElementsEnvironmentEvaluationFacultyFundingFutureGenetic MedicineGenomic medicineGoalsGrantGroup MeetingsHealth systemHeart DiseasesHospitalsInstitutionInternationalLeadershipLearningLung diseasesMentored Clinical Scientist Development ProgramMentorsMentorshipMetabolismMolecularObesityPathogenesisPhysiciansPositioning AttributeResearchResearch PersonnelResearch Project GrantsResourcesScientistTimeTrainingTraining ProgramsUnderrepresented MinorityUnited States National Institutes of Healthcardiogenesiscareercareer developmentcollaborative environmentdistractionemerging pathogenlaboratory facilitylung developmentmedical schoolsmeetingsmultidisciplinarynervous system disordernext generationnovel vaccinespediatric departmentpediatricianprogramsresearch and developmentresearch facilitytargeted treatmenttherapeutic targettherapeutic vaccinetraining opportunitytranslational physician
项目摘要
Project Summary
The goal of this renewal application is to continue our K12 training program for early career pediatricians with
both the aptitude and passion to become the next generation of basic and translational physician scientists. The
results of our first funding cycle have been excellent, and lessons learned are incorporated to further strengthen
the program. The overarching theme for the program is elucidation of the molecular and cellular pathogenesis
of childhood diseases, leading to identification of therapeutic targets. Our focus is career development in the
following areas where Vanderbilt has internationally recognized programs of discovery combined with a record
of excellence in research mentorship: 1) Lung Disease and Development, 2) Heart Disease and Development;
3) Obesity and Metabolism (including diabetes) 4) Neurological Disorders; 5) Cancer Biology, 6) Genetics and
Genomic Medicine, and 7) Infectious Diseases, including emerging pathogens. The program offers an integrated
pediatric department and medical school training program for four pediatric K12 scholars to receive up to three
years of support that includes intense scientific mentorship and personalized career development. The scholars
will have access to a cadre of well-established faculty including 33 carefully selected senior investigators, all with
sustained NIH funding coupled with a successful track record of mentoring early career scholars. Also, we have
selected 8 pediatric ‘next generation mentors’, with K or early R01 funding that will be well positioned for full
mentorship in the future. The Department of Pediatrics is fully integrated into the Vanderbilt School of Medicine
and health system, a leading NIH funded academic medical center. All departments, hospitals, research
laboratories and core facilities reside on a single campus offering an integrated research environment for
scholars. Through multiple training grants, there is a strong pipeline of future K12 scholars. Program leadership
will also conduct a national search to identify a group of K12 scholars, including underrepresented minorities,
that will thrive in this collaborative environment. Each scholar will have an individualized training program
developed by the PI and training directors in collaboration with a multidisciplinary mentorship team and will be
supported by a broad array of institutional and departmental resources. The primary focus for each scholar will
be their mentored research project, but they will have opportunities to participate in an array of training
opportunities to support their research and career development goals. To avoid distraction from research time,
we will carefully define required activities from optional program opportunities. Required elements include weekly
attendance at lab meetings and with their primary mentor, monthly group meetings with program leaders, six-
monthly scholar oversight committee meetings, and annual evaluations of scholars and program. They will also
have confidential face-to-face meetings with two outside advisors (Drs. Arnold Strauss and George Dover).
These plans provide an optimal environment for developing the next generation of pediatric physician scientists.
项目摘要
本次更新申请的目标是继续我们的K12培训计划,为早期职业儿科医生,
无论是资质和激情,成为下一代的基础和转化医学科学家。的
我们第一个供资周期的结果非常好,吸取的经验教训被纳入进一步加强
节目该计划的首要主题是阐明分子和细胞发病机制
儿童疾病,从而确定治疗目标。我们的重点是职业发展,
以下是范德比尔特拥有国际公认的发现计划和记录的领域
卓越的研究导师:1)肺部疾病和发展,2)心脏病和发展;
3)肥胖和代谢(包括糖尿病)4)神经系统疾病; 5)癌症生物学,6)遗传学和
基因组医学,和7)传染病,包括新兴病原体。该计划提供了一个综合的
儿科系和医学院的培训计划,为四名儿科K12学者提供最多三个
多年的支持,包括密集的科学指导和个性化的职业发展。学者
将拥有一支实力雄厚的教师队伍,其中包括33名精心挑选的高级调查员,所有人都拥有
持续的NIH资金,加上指导早期职业学者的成功记录。另外,我们有
选择了8名儿科“下一代导师”,K或早期R 01资金将很好地定位于全面
未来的导师。儿科系完全融入范德比尔特医学院
和卫生系统,一个领先的NIH资助的学术医疗中心。所有部门医院研究部门
实验室和核心设施位于一个单一的校园,提供一个综合的研究环境,
学者通过多种培训赠款,有一个强大的管道未来K12学者。项目领导
还将进行全国搜索,以确定一组K12学者,包括代表性不足的少数民族,
在这种合作环境中茁壮成长每位学者都将有一个个性化的培训计划
由PI和培训主任与多学科导师团队合作开发,并将
得到广泛的机构和部门资源的支持。每个学者的主要重点将是
是他们的指导研究项目,但他们将有机会参加一系列培训,
支持他们的研究和职业发展目标的机会。为了避免在研究时间分心,
我们将从可选的计划机会中仔细定义所需的活动。所需要素包括每周
参加实验室会议,与他们的主要导师,每月与项目负责人的小组会议,6-
每月举行一次学者监督委员会会议,并对学者和项目进行年度评估。他们还将
与两名外部顾问(Arnold Strauss博士和乔治多佛博士)进行保密的面对面会议。
这些计划为培养下一代儿科医生科学家提供了最佳环境。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Michael R. DeBaun其他文献
Incremental eligibility criteria for the BMT CTN 1507 haploidentical trial for children with sickle cell disease
- DOI:
10.1182/bloodadvances.2024014078 - 发表时间:
2024-12-10 - 期刊:
- 影响因子:
- 作者:
Tami D. John;Mark C. Walters;Hemalatha G. Rangarajan;Mahvish Q. Rahim;Christopher McKinney;Catherine M. Bollard;Ghada Abusin;Mary Eapen;Adetola A. Kassim;Michael R. DeBaun - 通讯作者:
Michael R. DeBaun
Evaluation of hemoglobin S percent threshold to prevent severe pain events: a secondary analysis of the SIT trial
- DOI:
10.1182/bloodadvances.2024013216 - 发表时间:
2024-11-26 - 期刊:
- 影响因子:
- 作者:
Jose Mejias;Alejandro R. Gonzalez-Barreto;Mark Rodeghier;Michael R. DeBaun - 通讯作者:
Michael R. DeBaun
Rationale and Design of a Randomized Controlled Double-Blind Internal Pilot Trial for Prevention of Recurrent Ischemic Priapism in Men with Sickle Cell Disease (PIN Trial)
- DOI:
10.1182/blood-2022-167023 - 发表时间:
2022-11-15 - 期刊:
- 影响因子:
- 作者:
Ibrahim Musa Idris;Aminu Abba Yusuf;Ismail Isa Ismail;Awwal Musa Borodo;Mustapha Shuaibu Hikima;Shehu Kana;Sani A Aji;Aisha Kuliya_Gwarzo;Mohammad Kabir;Jamil Aliyu Galadanci;Rukayya Alkassim;Nafiu Hussain;Mark Rodeghier;Aurthur Burnett;Michael R. DeBaun - 通讯作者:
Michael R. DeBaun
The Importance of Screening for Food Insecurity in Children with Sickle Cell Anemia: An Ancillary Study to the Severe Acute Malnutrition Feasibility Trial in Nigeria
- DOI:
10.1182/blood-2023-182833 - 发表时间:
2023-11-02 - 期刊:
- 影响因子:
- 作者:
Gabriela Ramirez Cuebas;Shehu Umar Abdullahi;Safiya Gambo;Hassan Adam Murtala;Halima Kabir;Khadija A. Shamsu;Garba Gwarzo;Sari A Acra;Virginia Stallings;Mark Rodeghier;Michael R. DeBaun;Lauren J Klein - 通讯作者:
Lauren J Klein
Academic pipeline initiatives in pediatrics
- DOI:
10.1038/s41390-021-01615-2 - 发表时间:
2021-06-08 - 期刊:
- 影响因子:3.100
- 作者:
Catherine M. Gordon;Margaret K. Hostetter;Michael R. DeBaun - 通讯作者:
Michael R. DeBaun
Michael R. DeBaun的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Michael R. DeBaun', 18)}}的其他基金
Clinical and genetic risk factors associated with adverse long-term health outcomes after curative therapies in individuals with sickle cell disease
镰状细胞病患者治疗后与不良长期健康结果相关的临床和遗传风险因素
- 批准号:
10596076 - 财政年份:2021
- 资助金额:
$ 44万 - 项目类别:
Clinical and genetic risk factors associated with adverse long-term health outcomes after curative therapies in individuals with sickle cell disease
镰状细胞病患者治疗后与不良长期健康结果相关的临床和遗传风险因素
- 批准号:
10154363 - 财政年份:2021
- 资助金额:
$ 44万 - 项目类别:
Clinical and genetic risk factors associated with adverse long-term health outcomes after curative therapies in individuals with sickle cell disease
镰状细胞病患者治疗后与不良长期健康结果相关的临床和遗传风险因素
- 批准号:
10371225 - 财政年份:2021
- 资助金额:
$ 44万 - 项目类别:
Cellular and Molecular Mechanisms of Acute Lung Injury in Sickle Cell Disease
镰状细胞病急性肺损伤的细胞和分子机制
- 批准号:
8468275 - 财政年份:2013
- 资助金额:
$ 44万 - 项目类别:
Phase 2 Study of Montelukast for the Treatment of Sickle Cell Anemia
孟鲁司特治疗镰状细胞性贫血的 2 期研究
- 批准号:
8727301 - 财政年份:2013
- 资助金额:
$ 44万 - 项目类别:
Cellular and Molecular Mechanisms of Acute Lung Injury in Sickle Cell Disease
镰状细胞病急性肺损伤的细胞和分子机制
- 批准号:
9069964 - 财政年份:2013
- 资助金额:
$ 44万 - 项目类别:
Cellular and Molecular Mechanisms of Acute Lung Injury in Sickle Cell Disease
镰状细胞病急性肺损伤的细胞和分子机制
- 批准号:
8722610 - 财政年份:2013
- 资助金额:
$ 44万 - 项目类别:
Phase 2 Study of Montelukast for the Treatment of Sickle Cell Anemia
孟鲁司特治疗镰状细胞性贫血的 2 期研究
- 批准号:
9405682 - 财政年份:2013
- 资助金额:
$ 44万 - 项目类别:
Cellular and Molecular Mechanisms of Acute Lung Injury in Sickle Cell Disease
镰状细胞病急性肺损伤的细胞和分子机制
- 批准号:
8999245 - 财政年份:2013
- 资助金额:
$ 44万 - 项目类别:
Phase 2 Study of Montelukast for the Treatment of Sickle Cell Anemia
孟鲁司特治疗镰状细胞性贫血的 2 期研究
- 批准号:
8568575 - 财政年份:2013
- 资助金额:
$ 44万 - 项目类别:
相似海外基金
Development of a driving aptitude assessment method to improve driving safety for the elderly
开发驾驶能力评估方法以提高老年人驾驶安全
- 批准号:
22K11357 - 财政年份:2022
- 资助金额:
$ 44万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Development of an e-learning system supported by artificial intelligence that applies aptitude treatment interaction
开发由人工智能支持、应用能力倾向治疗互动的电子学习系统
- 批准号:
22K02838 - 财政年份:2022
- 资助金额:
$ 44万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
SBIR Phase I: Validating and Scaling a Financial and Entrepreneurial Aptitude Assessment
SBIR 第一阶段:验证和扩展财务和创业能力评估
- 批准号:
2151767 - 财政年份:2022
- 资助金额:
$ 44万 - 项目类别:
Standard Grant
An empirical study on the interaction between language aptitude and instruction in second language acquisition
语言能力与二语习得教学交互作用的实证研究
- 批准号:
22K00799 - 财政年份:2022
- 资助金额:
$ 44万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Optimizing Second Language Vocabulary Instruction with Aptitude-Treatment Interaction
通过能力倾向治疗互动优化第二语言词汇教学
- 批准号:
20H01287 - 财政年份:2020
- 资助金额:
$ 44万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
A research on the aptitude of elementary school physical education teacher
小学体育教师素质调查
- 批准号:
19K11604 - 财政年份:2019
- 资助金额:
$ 44万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Development and Utilization of the Sign language Version of the Modern Language Aptitude Test
现代语言能力倾向测试手语版的开发与应用
- 批准号:
19K21764 - 财政年份:2019
- 资助金额:
$ 44万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
Exploring first-year factors that inhibit the graduation of local nursing students and Indicators of nursing aptitude.
探讨阻碍当地护生毕业的第一年因素及护理能力指标。
- 批准号:
19K14277 - 财政年份:2019
- 资助金额:
$ 44万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Optimal schedules of grammar learning: Types of grammatical knowledge and roles of aptitude
语法学习的最佳时间表:语法知识的类型和能力的作用
- 批准号:
18K12470 - 财政年份:2018
- 资助金额:
$ 44万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Search for genomic markers related to high aptitude temperament of guide dogs for the blind
寻找与导盲犬高适应性气质相关的基因组标记
- 批准号:
17K19317 - 财政年份:2017
- 资助金额:
$ 44万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)